FAKTOR-OPTIONSSCHEIN - BECTON DICKINSON AND CO. Stock

Certificat

DE000MC74YT1

Market Closed - Bid/Ask 12:11:41 2024-07-16 pm EDT After market 02:11:33 pm
0.57 EUR +3.64% Intraday chart for FAKTOR-OPTIONSSCHEIN - BECTON DICKINSON AND CO. 0.605 +6.14%
1 month-20.29%
3 months-29.49%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-16 0.57 +3.64%
24-07-15 0.55 -6.78%
24-07-12 0.59 +9.26%
24-07-11 0.54 +3.85%
24-07-10 0.52 +4.00%

Delayed Quote Börse Stuttgart

Last update July 16, 2024 at 12:11 pm EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN MC74YT
ISINDE000MC74YT1
Date issued 2020-03-16
Strike 180.9 $
Maturity Unlimited
Parity 75.88 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 17.69
Lowest since issue 0.49
Spread 0.01
Spread %1.67%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
226.1 USD
Average target price
277.8 USD
Spread / Average Target
+22.88%
Consensus